Cabozantinib 60mgTablet
Anti-Cancer

Cabozantinib 60mg

Cabozantinib S-Malate

Multi-kinase inhibitor targeting MET, VEGFR2, AXL, and RET pathways for advanced renal cell carcinoma and hepatocellular carcinoma. Cipla and Natco produce affordable generics for export.

Strengths

20mg / 40mg / 60mg

Packing

30 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Cabozantinib S-Malate 20mg / 40mg / 60mg
Dosage Form
Tablet
Available Strengths
20mg / 40mg / 60mg
Packing
30 tablets/bottle
Route of Administration
Oral, on empty stomach (do not eat for 2 hours before and 1 hour after)
Dosage
60mg once daily on empty stomach; dose reductions to 40mg then 20mg as needed
Indications
Advanced renal cell carcinoma, hepatocellular carcinoma after sorafenib, medullary thyroid cancer
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Diarrhea, fatigue, decreased appetite, palmar-plantar erythrodysesthesia, hypertension, nausea, weight loss
Precautions
GI perforation and fistula risk; hemorrhage risk; thrombotic events; wound healing complications; withhold before surgery

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sorafenib 200mgTablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg
Lenalidomide 25mgCapsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg
Imatinib 400mgTablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Cabozantinib 60mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote